Clinical Trials - HRTX

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT03922048Pediatric Postoperative Analgesia Herniorrhaphy StudyWITHDRAWNPHASE22023-072025-122025-11
NCT05434663Safety Study of Repeat Doses of SUSTOL in AdultsACTIVE_NOT_RECRUITINGPHASE42022-07-062025-102025-10
NCT04911062HTX-011 in Spinal SurgeryCOMPLETEDPHASE22022-04-072022-08-262022-07-29
NCT06109415A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.COMPLETEDPHASE42021-10-202022-07-292022-07-18
NCT06109428A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZECOMPLETEDPHASE42021-10-122022-04-072022-03-29
NCT05109312A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.ACTIVE_NOT_RECRUITINGPHASE42021-10-122024-062024-06
NCT04470622Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)TERMINATEDPHASE22020-07-202021-06-032021-04-09
NCT04398329Dose-Escalation Study of HTX-034 Following BunionectomyCOMPLETEDPHASE1, PHASE22020-05-182021-08-032021-07-01
NCT03955211HTX-011 Administration Study in Planned Caesarean Section ProcedureCOMPLETEDPHASE22019-06-242021-12-272021-12-03
NCT03974932Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) RegimenCOMPLETEDPHASE32019-06-052021-01-072020-12-07
NCT03907176Herniorrhaphy Study for Opioid EliminationCOMPLETEDPHASE32019-04-052021-11-222021-10-25
NCT03718039Phase 2 Bunionectomy HTX-011 Administration StudyCOMPLETEDPHASE22018-10-242019-03-112019-01-31
NCT03695367Phase 2 Herniorrhaphy Study for Opioid EliminationCOMPLETEDPHASE22018-10-012018-12-152018-11-20
NCT03705065Bupivacaine HCl PK and Safety in Augmentation MammoplastyCOMPLETEDPHASE42018-09-192018-11-052018-10-08
NCT04102267Extended Delivery of Bupivacaine Study in HerniorrhaphyCOMPLETEDPHASE42018-07-022018-10-262018-09-03
NCT03295721Bunionectomy Study for Postoperative Analgesia (EPOCH 1)COMPLETEDPHASE32017-10-242018-03-132018-01-08
NCT03237481Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)COMPLETEDPHASE32017-07-312018-01-162017-12-22
NCT03011333Phase 2B Upper Extremity Nerve Block StudyCOMPLETEDPHASE22017-01-142018-03-192018-02-01
NCT03015532Total Knee Arthroplasty Infiltration Study for Postoperative AnalgesiaCOMPLETEDPHASE22017-01-132018-05-162018-04-20
NCT02762929Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following BunionectomyCOMPLETEDPHASE22016-052017-032017-02
NCT02689258Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty SurgeryCOMPLETEDPHASE22016-02-232017-042017-03
NCT02504580A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal HerniorrhaphyCOMPLETEDPHASE22015-072017-042017-03
NCT02471898A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following BunionectomyCOMPLETEDPHASE22015-062015-092015-09
NCT02106494A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HECCOMPLETEDPHASE32014-032015-052015-05
NCT00343460APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for CancerCOMPLETEDPHASE32006-062009-022008-09